- 抑制劑
- 化合物庫
- 抗體
- 生物試劑
- 新產(chǎn)品
- 聯(lián)系我們
別名: LEE011 中文名稱:瑞博西利,瑞博西林
Ribociclib是一種可口服的,高度特異性CDK4/6抑制劑。
Ribociclib Chemical Structure
CAS: 1211441-98-3
細胞系 | 實驗類型 | 給藥濃度 | 孵育時間 | 活性描述 | 文獻信息 |
---|---|---|---|---|---|
LP8 | Growth Inhibition Assay | 3.33 μM | 24 h | decreases the proportion of cells in S phase | 25028469 |
LP6 | Growth Inhibition Assay | 3.33 μM | 24 h | decreases the proportion of cells in S phase | 25028469 |
LP3 | Growth Inhibition Assay | 3.33 μM | 24 h | decreases the proportion of cells in S phase | 25028469 |
449 | Growth Inhibition Assay | 3.33 μM | 24 h | decreases the proportion of cells in S phase | 25028469 |
778 | Growth Inhibition Assay | 3.33 μM | 24 h | decreases the proportion of cells in S phase | 25028469 |
LPS141 | Growth Inhibition Assay | 3.33 μM | 24 h | decreases the proportion of cells in S phase | 25028469 |
KOPN8 | Apoptosis assay | 0.5 uM | 3 hrs | Induction of apoptosis in human KOPN8 cells assessed as upregulation of cleaved PARP level at 0.5 uM after 3 hrs by Western blot analysis | 29407975 |
KOPN8 | Apoptosis assay | 0.5 uM | 24 hrs | Induction of apoptosis in human KOPN8 cells assessed as upregulation of cleaved PARP level at 0.5 uM pre-treated with NAC for 1 hr and measured after 24 hrs by Western blot analysis | 29407975 |
Fluc-labeled 4T1 | Antitumor assay | 130 mg/kg | 18 days | Antitumor activity against mouse Fluc-labeled 4T1 cells implanted in Balb/c mouse assessed as reduction in tumor weight at 130 mg/kg, ip administered daily for 18 days measured after 8 to 25 days | 29518312 |
LPS141 | Growth Inhibition Assay | 72 h | inhibits cell growth dose dependently | 25028469 | |
LP8 | Growth Inhibition Assay | 72 h | inhibits cell growth dose dependently | 25028469 | |
LP6 | Growth Inhibition Assay | 72 h | inhibits cell growth dose dependently | 25028469 | |
LP3 | Growth Inhibition Assay | 72 h | inhibits cell growth dose dependently | 25028469 | |
449 | Growth Inhibition Assay | 72 h | inhibits cell growth dose dependently | 25028469 | |
778 | Growth Inhibition Assay | 72 h | inhibits cell growth dose dependently | 25028469 | |
Rh30 | Growth Inhibition Assay | 72 h | IC50>10000 nM | 25810375 | |
Rh5 | Growth Inhibition Assay | 72 h | IC50>10000 nM | 25810375 | |
CW9019 | Growth Inhibition Assay | 72 h | IC50=9912 nM | 25810375 | |
Rh41 | Growth Inhibition Assay | 72 h | IC50=7187 nM | 25810375 | |
Rh28 | Growth Inhibition Assay | 72 h | IC50=845 nM | 25810375 | |
SKNAS | Growth Inhibition Assay | 72 h | IC50>10000 nM | 25810375 | |
IMRS | Growth Inhibition Assay | 72 h | IC50=873 nM | 25810375 | |
Myoblast | Growth Inhibition Assay | 72 h | IC50=1035 nM | 25810375 | |
DFSP105 | Growth Inhibition Assay | 24 h | GI50=276 nM | 25852058 | |
IMR5 | Growth Inhibition Assay | 24 h | IC50=126 nM | 24045179 | |
BE2C | Growth Inhibition Assay | 24 h | IC50=134 nM | 24045179 | |
1643 | Growth Inhibition Assay | 24 h | IC50=147 nM | 24045179 | |
SKNSH | Growth Inhibition Assay | 24 h | IC50=148 nM | 24045179 | |
SY5Y | Growth Inhibition Assay | 24 h | IC50=154 nM | 24045179 | |
NGP | Growth Inhibition Assay | 24 h | IC50=175 nM | 24045179 | |
KELLY | Growth Inhibition Assay | 24 h | IC50=220 nM | 24045179 | |
CHP134 | Growth Inhibition Assay | 24 h | IC50=273 nM | 24045179 | |
NLF | Growth Inhibition Assay | 24 h | IC50=328 nM | 24045179 | |
LAN5 | Growth Inhibition Assay | 24 h | IC50=429 nM | 24045179 | |
NB69 | Growth Inhibition Assay | 24 h | IC50=738 nM | 24045179 | |
SKNDZ | Growth Inhibition Assay | 24 h | IC50=801 nM | 24045179 | |
NBSD | Growth Inhibition Assay | 24 h | IC50=1900 nM | 24045179 | |
SKNF1 | Growth Inhibition Assay | 24 h | IC50=3500 nM | 24045179 | |
EBC1 | Growth Inhibition Assay | 24 h | IC50=6400 nM | 24045179 | |
SKNAS | Growth Inhibition Assay | 24 h | IC50>10000 nM | 24045179 | |
NB16 | Growth Inhibition Assay | 24 h | IC50>10000 nM | 24045179 | |
RPE1 | Growth Inhibition Assay | 24 h | IC50>10000 nM | 24045179 | |
Sf21 | Function assay | 10 mins | Inhibition of recombinant human full length N-terminal GST-tagged CDK4/Cyclin-D3 co-expressed in baculovirus infected sf21 cells using Rb substrate in presence of [gamma33P]ATP after 10 mins by scintillation counting method, IC50 = 0.013 μM. | 29518312 | |
Sf21 | Function assay | 10 mins | Inhibition of recombinant human full length C-terminal 6His-tagged CDK9/Cyclin-T1 co-expressed in baculovirus infected sf21 cells using PDKtide substrate in presence of [gamma33P]ATP after 10 mins by scintillation counting method, IC50 = 0.197 μM. | 29518312 | |
HepG2 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human HepG2 cells after 72 hrs by CelTiter-Glo assay, EC50 = 0.2862 μM. | 29407975 | |
SEM | Antiproliferative assay | 72 hrs | Antiproliferative activity against human SEM cells after 72 hrs by CelTiter-Glo assay, EC50 = 0.4605 μM. | 29407975 | |
KOPN8 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human KOPN8 cells after 72 hrs by CelTiter-Glo assay, EC50 = 0.5008 μM. | 29407975 | |
NCI-H1299 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human NCI-H1299 cells assessed as reduction in cell viability after 72 hrs by CCK8 assay, IC50 = 5.46 μM. | 29518312 | |
T47D | Growth inhibition assay | 72 hrs | Growth inhibition of human T47D cells incubated for 72 hrs by CCK8 assay, IC50 = 6.227 μM. | 28651979 | |
T47D | Cytotoxicity assay | 72 hrs | Cytotoxicity against human T47D cells assessed as reduction in cell viability after 72 hrs by CCK8 assay, IC50 = 6.23 μM. | 29518312 | |
H1299 | Growth inhibition assay | 72 hrs | Growth inhibition of human H1299 cells incubated for 72 hrs by CCK8 assay, IC50 = 7.637 μM. | 28651979 | |
Hep3B | Cell cycle assay | 24 hrs | Cell cycle arrest in human Hep3B cells assessed as accumulation at G0/G1 phase after 24 hrs by propidium iodide staining based flow cytometry | 29518312 | |
HepG2 | Cell cycle assay | 24 hrs | Cell cycle arrest in human HepG2 cells assessed as accumulation at G0/G1 phase after 24 hrs by propidium iodide staining based flow cytometry | 29518312 | |
A549 | Cell cycle assay | 24 hrs | Cell cycle arrest in human A549 cells assessed as accumulation at G0/G1 phase after 24 hrs by propidium iodide staining based flow cytometry | 29518312 | |
NCI-H460 | Cell cycle assay | 24 hrs | Cell cycle arrest in human NCI-H460 cells assessed as accumulation at G0/G1 phase after 24 hrs by propidium iodide staining based flow cytometry | 29518312 | |
T47D | Cell cycle assay | 24 hrs | Cell cycle arrest in human T47D cells assessed as accumulation at G0/G1 phase after 24 hrs by propidium iodide staining based flow cytometry | 29518312 | |
MDA-MB-231 | Cell cycle assay | 24 hrs | Cell cycle arrest in human MDA-MB-231 cells assessed as accumulation at G0/G1 phase after 24 hrs by propidium iodide staining based flow cytometry | 29518312 | |
T47D | Cell cycle assay | 24 hrs | Induction of cell cycle arrest in human T47D cells assessed as increase in G0/G1 phase accumulation incubated for 24 hrs by flow cytometry | 28651979 | |
點擊查看更多細胞系數(shù)據(jù) |
產(chǎn)品描述 | Ribociclib是一種可口服的,高度特異性CDK4/6抑制劑。 | ||||
---|---|---|---|---|---|
特性 | 口服生物有效的CDK4/6選擇性抑制劑,處于Ⅲ期臨床測試,用于晚期乳腺癌的治療。 | ||||
靶點 |
|
體外研究(In Vitro) | ||||
體外研究活性 | LEE011是一種CDK4/CDK6的雙重抑制劑,能夠顯著抑制17種神經(jīng)細胞瘤中的12種的生長,平均IC50值是307 nM。對神經(jīng)細胞瘤的抑制主要是抑制細胞的生長,受到G1細胞周期阻滯和細胞衰老的調(diào)控。 |
|||
---|---|---|---|---|
細胞實驗 | 細胞系 | BE2C, IMR5, 1643, SY5Y, CHP134, SKNSH, NGP, KELLY, LAN5, NLF, NB69, SKNDZ, NBSD, NBLS, SKNFI, EBC1, SKNAS, NB16, RPE1細胞系。 | ||
濃度 | 10 μM | |||
孵育時間 | ~100小時 | |||
方法 | 將板中優(yōu)先附著基底生長的神經(jīng)母細胞瘤細胞系以一式三份種植于Xcelligence實時細胞電子傳感系統(tǒng),用4個劑量梯度的抑制劑和DMSO為對照處理細胞24小時。連續(xù)監(jiān)測細胞約100個小時,IC50通過以下方法測得:通過繪制細胞指數(shù)為時間的函數(shù)產(chǎn)生生長曲線,以在治療開始時細胞指數(shù)為1作為標(biāo)準(zhǔn)。從治療開始到處理96小時后,生長曲線下的面積通過基線下面積為1(治療開始時的細胞指數(shù))進行計算。積分面積以DMSO處理的對照組作為背景。抑制劑比上對照組的值取非線性對數(shù)值來計算。所有的實驗至少重復(fù)一次。 |
|||
實驗圖片 | 檢測方法 | 檢測指標(biāo) | 實驗圖片 | PMID |
Western blot |
感谢您访问我们的网站,您可能还对以下资源感兴趣: 成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天 |